POSITIVE EFFECTS OF SH2 DOMAIN-CONTAINING TYROSINE PHOSPHATASE SHP-1 ON EPIDERMAL GROWTH FACTOR-STIMULATED AND INTERFERON-GAMMA-STIMULATED ACTIVATION OF STAT TRANSCRIPTION FACTORS IN HELA-CELLS
M. You et Zz. Zhao, POSITIVE EFFECTS OF SH2 DOMAIN-CONTAINING TYROSINE PHOSPHATASE SHP-1 ON EPIDERMAL GROWTH FACTOR-STIMULATED AND INTERFERON-GAMMA-STIMULATED ACTIVATION OF STAT TRANSCRIPTION FACTORS IN HELA-CELLS, The Journal of biological chemistry, 272(37), 1997, pp. 23376-23381
SHP-1 (also known as PTP1C, SHPTP-1, SHP, and HCP) is an SH2 domain-co
ntaining protein-tyrosine phosphatase. We have stably overexpressed th
e native form and a catalytically inactive cysteine to serine mutant o
f the enzyme, SHP-1-(Cys --> Ser), in human cervical carcinoma HeLa ce
lls, Following stimulation of the cells with epidermal growth factor (
EGF) and interferon-gamma (INF-gamma), signal transducers and activato
rs of transcription (STAT) activity was analyzed by using two P-32-lab
eled DNA probes, namely hSIE which is derived from a high affinity mut
ant form of the serum-inducible element in the c-fos promotor and GAS
which resembles the INF-gamma activation site, EGF induced hSIE bindin
g activity only, and the activity was suppressed by similar to 70% whe
n the inactive mutant. form of SHP-1 was expressed but was essentially
unaffected by expression of the native enzyme. INF-gamma treatment re
sulted in appearance of both hSIE and GAS binding activities. While ex
pression of the inactive mutant reduced the activities by 30-50%, the
native enzyme caused a 20-30% increase. Consistent with effects on STA
T activation, altered SHP-1 expression also affected EGF-induced activ
ation of the mitogen-activated protein kinase pathway; expression of S
HP-1-(Cys --> Ser) inhibited activity of MEK by similar to 25%, wherea
s expression of SHP-1 resulted in a similar to 25% increase. Further s
tudies revealed that overexpression of SHP-1 caused decreased tyrosine
phosphorylation of the EGF receptor and that EGF induced phosphorylat
ion and recruitment of SHP-1. Together, the data suggest that SHP-1 is
positively involved in EGF-and INF-gamma-induced STAT activation in n
on-hematopoietic HeLa cells and that, in the EGF signaling system, SHP
-1 functions at least partly by modulating tyrosine phosphorylation of
EGF receptor.